Wells Fargo & Company Portfolio Holdings

Wells Fargo & Company

  • $468 Billion
  • Q2 2025

Wells Fargo & Company has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $468 Billion distributed in 17891 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $16.5B, Spdr S&P 500 ETF Trust with a value of $12.4B, Apple Inc. with a value of $11.9B, Ishares Core S&P 500 ETF with a value of $11B, and Nvidia Corp with a value of $9.06B.

Examining the 13F form we can see an increase of $39.4B in the current position value, from $429B to 468B. Also it can be appreciated an additional of 567 stocks purchases and 87 closed positions.

Wells Fargo & Company is based out at San Francisco, CA

Below you can find more details about Wells Fargo & Company portfolio as well as his latest detailed transactions.

Portfolio value $468 Billion
ETFs: $202 Billion
Technology: $77.2 Billion
Financial Services: $40.4 Billion
Industrials: $30.7 Billion
Healthcare: $26.3 Billion
Consumer Cyclical: $26.3 Billion
Communication Services: $19.9 Billion
Consumer Defensive: $16.4 Billion
Other: $28.4 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.36B
$18.3 Million 0.0% of portfolio
834,209
Q2 2025 Added 1.57%
World Kinect Corporation
-
$0 0.0% of portfolio
-
Q2 2025 Added 15.61%
$3.23B
$2.71 Million 0.0% of portfolio
42,528
Q2 2025 Added 61.59%
Worthington Stl Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 5.71%
$5.32B
$6.64 Million 0.0% of portfolio
189,696
Q2 2025 Added 0.91%
$56.3M
$1,000 0.0% of portfolio
1,015
Q2 2025 Reduced 81.92%
$3.43B
$9.92 Million 0.0% of portfolio
180,412
Q2 2025 Reduced 17.86%
$0
$219,000 0.0% of portfolio
18,597
Q2 2025 Reduced 25.91%
$7.73B
$1.17 Million 0.0% of portfolio
14,411
Q2 2025 Reduced 63.63%
$773M
$629,000 0.0% of portfolio
36,062
Q2 2025 New
X4 Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$0
$2.62 Million 0.0% of portfolio
419,467
Q2 2025 Added 140.95%
$0
$0 0.0% of portfolio
0
Q2 2025 Sold Out
$90.4M
$0 0.0% of portfolio
149
Q2 2025 Reduced 98.75%
$463M
$362,000 0.0% of portfolio
46,133
Q2 2025 Added 16.91%
$1.5B
$941,000 0.0% of portfolio
74,928
Q2 2025 Added 6.17%
$992M
$375,000 0.0% of portfolio
80,366
Q2 2025 Added 15.0%
$657M
$926,000 0.0% of portfolio
175,878
Q2 2025 Added 10.49%
-
$0 0.0% of portfolio
-
Q1 2025 Added 100.0%
$326M
$135,000 0.0% of portfolio
5,387
Q2 2025 Added 18.5%
$2.12B
$968,000 0.0% of portfolio
28,651
Q2 2025 Added 7.24%
Xos Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 7,500.0%
$7.8B
$342,000 0.0% of portfolio
16,972
Q2 2025 Added 38.9%
$1.03B
$1.52 Million 0.0% of portfolio
42,457
Q2 2025 Reduced 0.28%
$17.2B
$70,000 0.0% of portfolio
3,967
Q2 2025 Reduced 26.07%
Xperi Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 6.14%
$759M
$2.16 Million 0.0% of portfolio
239,176
Q2 2025 Reduced 9.64%
$213M
$1.04 Million 0.0% of portfolio
138,497
Q2 2025 Added 1,030.31%
$72.5M
$0 0.0% of portfolio
1
Q2 2024 Reduced 99.73%
Xwell Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 150.0%
$372M
$85,000 0.0% of portfolio
19,037
Q2 2025 Added 6.64%
$1.24B
$13,000 0.0% of portfolio
2,000
Q2 2024 New
$66M
$8,000 0.0% of portfolio
9,000
Q1 2025 Reduced 18.18%
$2.18B
$2.39 Million 0.0% of portfolio
69,833
Q2 2025 Added 81.43%
$2.91B
$5.73 Million 0.0% of portfolio
181,654
Q2 2025 Added 54.31%
$973M
$497,000 0.0% of portfolio
58,506
Q2 2025 Added 4.45%
$454M
$430,000 0.0% of portfolio
13,620
Q2 2025 Reduced 18.77%
$13.4B
$54,000 0.0% of portfolio
1,732
Q2 2025 Reduced 40.19%
$18.8B
$6.87 Million 0.0% of portfolio
153,710
Q2 2025 Reduced 9.42%
$3.36B
$6.1 Million 0.0% of portfolio
174,480
Q2 2025 Added 25.68%
$51.2M
$6,000 0.0% of portfolio
1,659
Q1 2025 Added 49.59%
Zenas Biopharma Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 27.7%
$80.3M
$2,000 0.0% of portfolio
2,278
Q2 2025 Reduced 93.56%
$3.17B
$4.49 Million 0.0% of portfolio
289,964
Q2 2025 Added 166.97%
$194M
$55,000 0.0% of portfolio
17,308
Q2 2025 Added 1,630.8%
$170M
$147,000 0.0% of portfolio
29,853
Q2 2025 Reduced 2.87%
$1.64B
$914,000 0.0% of portfolio
30,216
Q2 2025 Added 9.85%
$14.2B
$3.37 Million 0.0% of portfolio
48,159
Q2 2025 Added 4.01%
$4.54B
$910,000 0.0% of portfolio
13,298
Q2 2025 Reduced 4.91%

Summary

  • Portfolio
  • No. of Stocks 17,891
  • Current Value $468 Billion
  • Prior Value $429 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 567 stocks
  • Additional Purchases 3,190 stocks
  • Sold out of 87 stocks
  • Reduced holdings in 2,289 stocks
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email